![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Mol. Neurosci. , 28 November 2023
Sec. Molecular Signalling and Pathways
Volume 16 - 2023 | https://doi.org/10.3389/fnmol.2023.1336871
This article is a correction to:
A role for pathogenic autoantibodies in small fiber neuropathy?
A corrigendum on
A role for pathogenic autoantibodies in small fiber neuropathy?
by Daifallah, O., Farah, A., and Dawes, J. M. (2023). Front. Mol. Neurosci. 16:1254854. doi: 10.3389/fnmol.2023.1254854
In the published article, the funding statement was mistakenly not included in the publication. The Funding statement appears below.
JD and AF were funded by the Medical Research Council (MR/V003534/1). OD was funded by a King Saud University Fellowship from the Saudi Arabian Cultural Bureau.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: autoantibodies, small fiber neuropathy (SFN), neuropathic pain (NeP), intravenous immunoglobulin (IVIG), passive transfer models, novel autoantibodies
Citation: Daifallah O, Farah A and Dawes JM (2023) Corrigendum: A role for pathogenic autoantibodies in small fiber neuropathy? Front. Mol. Neurosci. 16:1336871. doi: 10.3389/fnmol.2023.1336871
Received: 11 November 2023; Accepted: 15 November 2023;
Published: 28 November 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Daifallah, Farah and Dawes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: John M. Dawes, am9obi5kYXdlc0BuZGNuLm94LmFjLnVr
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.